fbpx

Tag Index  /  Showing 1 - 8 of 8 results for “genome”

Healthcare Opinion Science

Insurance Roadblocks Threaten to Limit Use of Genomic Tests

Resistance from insurance companies threatens to slow innovation that could dramatically improve patient outcomes from genomic testing.   More

Bio & Life Sciences

CRISPR Community Wrestles With Potential and Peril of Gene Editing

Scientists, academics and other stakeholders gathering in Boston lauded the potential of what CRISPR-powered innovation could offer society — and grappled with potential negative or unintended consequences from the still-nascent technology.   More

Bio & Life Sciences Healthcare Society

Meeting My Genome: This Expensive Test Still Isn’t for Everyone

Earlier this year, I moderated a panel discussion at Techonomy Bio and asked speakers whether genome sequencing was ready for the average consumer. Their responses were split. Having now just gotten my own genome sequenced, I can say definitively: yes it’s ready, and no it isn’t.   More

Bio & Life Sciences Business

Genes Can’t Be Patented, Supreme Court Tells Myriad

"A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated," the Supreme Court has ruled today unanimously. The 20-page decision written by Justice Thomas added that synthetic DNA, also known as complementary DNA or cDNA, "is patent eligible because it is not naturally occurring."   More

Bio & Life Sciences

Why Not Sequence Your Genome?

"Would you have your genome sequenced if you could afford it?" That question is posed in an (unscientific) online survey accompanying the final segment of NPR's "$1,000 Genome" series, which has been taking a look at the promise and perils of genome sequencing.   More

Bio & Life Sciences

Could Genomics Inform Your Diet?

Dean Ornish's column, Eating for Health, Not Weight, in yesterday's New York Times explained the scientific arguments for how a plant-based diet is better than a low carb Atkins-type diet for improving health and reducing disease. And he points to proof in the genome.   More

Bio & Life Sciences

23andMe Opens Up to App Developers, But Beware

If you've had your genome sequenced, there will soon be apps for that. Personal genome sequencing company 23andMe this week opened up its application program interface to allow third-party developers to build "a broad range of new applications and tools for the 23andMe community generated from the company’s data sets."   More

Bio & Life Sciences

How “Cloud” Services Democratize DNA Sequencing

DNAnexus is providing genomic storage and analysis tools in the cloud. Techonomy Contributing Editor Adrienne Burke spoke with the company's leadership recently about what their innovative approach to managing this unique brand of big data means to scientific research, personalized medicine, and individuals who’ve had their DNA sequenced.   More